Product Description
Next-generation sequencing refers to non-Sanger-based high-throughput DNA sequencing technologies. Millions or billions of DNA strands can be sequenced in parallel, yielding substantially more throughput and minimizing the need for the fragment-cloning methods that are often used in Sanger sequencing of genomes.
The Next-Generation Sequencing market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Next-Generation Sequencing market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Next-Generation Sequencing Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Next-Generation Sequencing market are:
Illumina, Inc.
Oxford Nanopore Technologies, Ltd.
Beijing Genomics Institute
454 Life Sciences Corporation (Roche Holding AG)
Macrogen Inc.
Thermo Fisher Scientific, Inc.
Pacific Biosciences of California, Inc.
Qiagen N.V.
Gatc Biotech AG
Perkinelmer, Inc.
Agilent Technologies, Inc.
Eurofins Scientific
Most important types of Next-Generation Sequencing products covered in this report are:
Consumables
Platforms Services
Most widely used downstream fields of Next-Generation Sequencing market covered in this report are:
Diagnostics
Biomarkers and Cancer
Reproductive Health
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.